The burden of Herpes Zoster: A prospective population based study

被引：115

作者：

Scott, FT

Johnson, RW

Leedham-Green, M

Davies, E

Edmunds, WJ

Breuer, J

机构：

[1] Inst Cell & Mol Sci, Skin Virus Lab, London E1 1BB, England

[2] United Bristol Hosp, Bristol BS2 8HW, Avon, England

[3] Univ Bristol, Bristol BS2 8HW, Avon, England

[4] Hlth Protect Agency, Modelling & Econ Unit, London NW9 5EQ, England

来源：

VACCINE | 2006年 / 24卷 / 09期

关键词：

Herpes Zoster; shingles; burden of disease; post herpetic neuralgia;

D O I：

10.1016/j.vaccine.2005.09.026

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We analysed prospectively the medical, societal and economic burden among patients from 1,8 general practices in East London, serving 158,716 patients who presented to their general practitioners with acute Herpes Zoster over an 8-month period. One hundred and eighty-six patients with HZ were seen by GPs during the study period, of whom 96 were referred, 70 enrolled and 65 completed. PHN Occurred in 13.4% of patients. The average overall cost of HZ in the first 6 months was calculated at;E524 per patient. Medical costs were highest in those aged over 65 and societal costs highest in those aged under 65 years. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：1308 / 1314

页数：7

共 26 条

[1]

Alper BS, 2000, J FAM PRACTICE, V49, P255

[2]

Arani RB, 2001, STAT MED, V20, P2429, DOI 10.1002/sim.851

[3] Valuing outcomes in health care: A comparison of willingness to pay and quality-adjusted life-years [J].